5Nguyen ND, Ahlborg HG, Center JR. Residual lifetime risk offractures in women and men[J]. Bone MinerRes,2007,22(6) :781 -788.
6Kazuhirok, Mashida T, Kouichi K, et al. Comparison of markers forbone form Katiom and resorption in premenopansal and postmenopausal subjects, and osteoporosis patients [ J ]. J Clin EndocrinolMetab, 1995, 80:2447.
7Warriner AH ,Saag KG.Osteoporosis diagnosis and medical treatment[J].Orthop Clin North Am, 2013,44(2):125-135.
8Das S, Crockett JC. Osteoporosis-a current view of pharmaco- logical prevention and treatment [ J]. Drug Des Devel Ther, 2013,31 (7) : 435-448.
9Orimo H,Nakamura T,Hosoi T,et al.Japanese 2011 guide- lines for prevention and treatment of osteoporosis-execu- tire summary [ J ]. Arch Osteoporos , 2012 , 7 (1-2) : 3-20.
10Matthias Wacker, Michael F Holick.Vitamin D-Effects on skeletal and Extraskeletal Health and the Need for Supplementation [J ]. Nutrients, 2013 , 5(1) : 111-148.
